[HTML][HTML] Reconsideration of amyloid hypothesis and tau hypothesis in Alzheimer's disease
F Kametani, M Hasegawa - Frontiers in neuroscience, 2018 - frontiersin.org
The so-called amyloid hypothesis, that the accumulation and deposition of oligomeric or
fibrillar amyloid β (Aβ) peptide is the primary cause of Alzheimer's disease (AD), has been …
fibrillar amyloid β (Aβ) peptide is the primary cause of Alzheimer's disease (AD), has been …
Neuronal cell death mechanisms in major neurodegenerative diseases
Neuronal cell death in the central nervous system has always been a challenging process to
decipher. In normal physiological conditions, neuronal cell death is restricted in the adult …
decipher. In normal physiological conditions, neuronal cell death is restricted in the adult …
[HTML][HTML] The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives
Ten years ago we first proposed the Alzheimer's disease (AD) mitochondrial cascade
hypothesis. This hypothesis maintains that gene inheritance defines an individual's baseline …
hypothesis. This hypothesis maintains that gene inheritance defines an individual's baseline …
[HTML][HTML] Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies
Z Chen, C Zhong - Progress in neurobiology, 2013 - Elsevier
Alzheimer's disease (AD) is an age-related devastating neurodegenerative disorder, which
severely impacts on the global economic development and healthcare system. Though AD …
severely impacts on the global economic development and healthcare system. Though AD …
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease
CR Jack Jr, VJ Lowe, SD Weigand, HJ Wiste… - Brain, 2009 - academic.oup.com
The purpose of this study was to use serial imaging to gain insight into the sequence of
pathologic events in Alzheimer's disease, and the clinical features associated with this …
pathologic events in Alzheimer's disease, and the clinical features associated with this …
Brain fuel metabolism, aging, and Alzheimer's disease
Lower brain glucose metabolism is present before the onset of clinically measurable
cognitive decline in two groups of people at risk of Alzheimer's disease---carriers of …
cognitive decline in two groups of people at risk of Alzheimer's disease---carriers of …
Abnormal brain cholesterol homeostasis in Alzheimer's disease—a targeted metabolomic and transcriptomic study
VR Varma, H Büşra Lüleci, AM Oommen… - npj Aging and …, 2021 - nature.com
The role of brain cholesterol metabolism in Alzheimer's disease (AD) remains unclear.
Peripheral and brain cholesterol levels are largely independent due to the impermeability of …
Peripheral and brain cholesterol levels are largely independent due to the impermeability of …
Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial
JA Luchsinger, T Perez, H Chang… - Journal of …, 2016 - content.iospress.com
Diabetes and hyperinsulinemia may be risk factors for Alzheimer's disease (AD). We
conducted a pilot study of metformin, a medication efficacious in treating and preventing …
conducted a pilot study of metformin, a medication efficacious in treating and preventing …
Prediction and classification of Alzheimer's disease based on combined features from apolipoprotein-E genotype, cerebrospinal fluid, MR, and FDG-PET imaging …
Alzheimer's disease (AD), including its mild cognitive impairment (MCI) phase that may or
may not progress into the AD, is the most ordinary form of dementia. It is extremely important …
may not progress into the AD, is the most ordinary form of dementia. It is extremely important …
The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease
MJ McManus, MP Murphy, JL Franklin - Journal of Neuroscience, 2011 - Soc Neuroscience
Considerable evidence suggests that mitochondrial dysfunction and oxidative stress
contribute to the progression of Alzheimer's disease (AD). We examined the ability of the …
contribute to the progression of Alzheimer's disease (AD). We examined the ability of the …